Key facts
- This page summarizes Fred E. Cohen's Form 4 filing for CareDx, Inc. (CDNA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jun 2024, 16:42.
Fred E. Cohen - 14 Jun 2024 Form 4 Insider Report for CareDx, Inc. (CDNA)
- Reporting relationship
- Director
- Issuer ticker
- CDNA
- Reported as of
- 14 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jun 2024, 16:42:33 UTC
- Prior SEC filing
- 14 Jun 2024
- Next SEC filing
- 08 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Fred E. Cohen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Fred E. Cohen filed Form 4 for CareDx, Inc. (CDNA) on 18 Jun 2024.
Change
- Previous filing in this sequence was filed on 14 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDNA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,570
- Change %
- +8%
- Price
- $0.000000
- Shares after
- 143,162
- Date
- 14 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDNA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +16,048
- Change %
- Price
- $0.000000
- Shares after
- 16,048
- Date
- 14 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,048
- Exercise price
- $9.35
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported securities are represented by restricted stock units which shall vest in one installment on June 14, 2025.
Footnote F2
1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025.